Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

被引:6
|
作者
Nakada, K
Ishibashi, T
Takei, T
Hirata, K
Shinohara, K
Katoh, S
Zhao, SJ
Tamaki, N
Noguchi, Y
Noguchi, S
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan
[2] Noguchi Tyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
salivary gland; radioiodine therapy; thyroid cancer; amifostine;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Salivary gland dysfunction is one of the common side effects of high-dose radioiodine therapy for thyroid cancer. The purpose of this study was to determine whether an early start of sucking lemon candy decreases salivary gland injury after radioiodine therapy. Methods: The incidence of the side effects of radioiodine therapy on the salivary glands was prospectively and longitudinally investigated in 2 groups of patients with postsurgical differentiated thyroid cancer with varying regimens for sucking lemon candy. From August 1999 to October 2000, 116 consecutive patients were asked to suck 1 or 2 lemon candies every 2-3 h in the daytime of the first 5 d after radioiodine therapy (group A). Lemon candy sucking was started within 1 h after radioiodine ingestion. From November 2000 to June 2002, 139 consecutive patients (group B) were asked to suck lemon candies in a manner similar to that of group A. In the group B, lemon candies were withheld until 24 h after the ingestion of radioiodine. Patients with salivary gland disorders, diabetes, collagen tissue diseases, or a previous history of radioiodine therapy or external irradiation to the neck were excluded. Thus, 105 patients in group A and 125 patients in group B were available for analysis. There were no statistical differences in the mean age (55.2 y vs. 58.5 y), average levels of serum free thyroxine (L-3,5,3',5'-tetraiodothyronine) (0.40 ng/dL vs. 0.47 ng/dL), and the mean dose of I-131 administered (3.96 GBq vs. 3.87 GBq) between the 2 groups. The onset of salivary side effects was monitored during hospital admission and regular follow-up on the basis of interviews with patients, a visual analog scale, and salivary gland scintigraphy using Tc-99m-pertechnetate. When a patient showed a persistent (>4 mo) dry mouth associated with a nonfunctioning pattern on salivary gland scintigraphy, a diagnosis of xerostomia was established. Results: The incidences of sialoadenitis, hypogeusia or taste loss, and dry mouth with or without repeated sialadenitis in group A versus group B were 63.8% versus 36.8% (P < 0.001), 39.0% versus 25.6% (P < 0.01), and 23.8% versus 11.2% (P < 0.005), respectively. Permanent xerostomia occurred in 15 patients in group A (14.3%) and 7 patients in group B (5.6%) (P < 0.05). In both groups, bilateral involvement of the parotid gland was the most frequently seen and was followed by bilateral involvement of the submandibular gland. Conclusion: An early start of sucking lemon candy may induce a significant increase in salivary gland damage. Lemon candy should not be given until 24 h after radioiodine therapy.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 50 条
  • [1] Re: Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Lam, MGEH
    van Isselt, JW
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (12) : 2118 - 2118
  • [2] Does lemon candy decrease salivary gland damages following radioiodine therapy for thyroid cancer?
    Nakada, K
    Hirata, K
    Takei, T
    Katoh, C
    Tsukamoto, S
    Tamaki, N
    Yamashita, H
    Noguchi, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 41P - 41P
  • [3] Relationship between lemon sucking and salivary gland damage after radioiodine therapy for thyroid cancer
    Yilmaz, S.
    Kabasakal, L.
    Dumlu, A.
    Elcin, M. A.
    Uslu, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S413 - S414
  • [4] Does vitamin-E Decrease Salivary Gland Damage After Radioiodine Therapy in Patients with Thyroid Cancer?
    Beiki, D.
    Fallahi, B.
    Abedi, S. M.
    Mokarami, B.
    Fard-Esfahani, A.
    Eftekhari, M.
    Gilani, K. Ansari
    Gholamrezanezhad, A.
    Saghari, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S465 - S465
  • [5] Salivary gland toxicity after radioiodine therapy for thyroid cancer
    Hyer, S.
    Kong, A.
    Pratt, B.
    Harmer, C.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (01) : 83 - 86
  • [6] Salivary Gland Malignancy and Radioiodine Therapy for Thyroid Cancer
    Klubo-Gwiezdzinska, Joanna
    Van Nostrand, Douglas
    Burman, Kenneth D.
    Vasko, Vasyl
    Chia, Stanley
    Deng, Tom
    Kulkarni, Kanchan
    Wartofsky, Leonard
    [J]. THYROID, 2010, 20 (06) : 647 - 651
  • [7] Quantitative assessment of salivary gland function in thyroid cancer patients after radioiodine therapy
    Fard-Estahani, A
    Olamie, R
    Eftekhari, M
    Saghari, M
    Fallahi, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S23 - S24
  • [9] Reduction of Salivary Gland Damage During Radioiodine Therapy for Differentiated Thyroid Cancers
    Byeong-Cheol Ahn
    [J]. Nuclear Medicine and Molecular Imaging, 2020, 54 : 126 - 127
  • [10] Salivary gland function in thyroid cancer patients submitted to radioiodine therapy
    Almeida, J.
    Sanabria, A.
    Lima, E.
    Kowalski, L. P.
    [J]. ORAL ONCOLOGY, 2007, : 219 - 219